Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022

Author:

Wise Mark G.ORCID,Karlowsky James A.,Mohamed Naglaa,Hermsen Elizabeth D.,Kamat ShwetaORCID,Townsend AndyORCID,Brink Adrian,Soriano AlexORCID,Paterson David L.ORCID,Moore Luke S.P.ORCID,Sahm Daniel F.

Funder

Pfizer

Publisher

Elsevier BV

Reference27 articles.

1. Global burden of bacterial antimicrobial resistance in 2019: a systemic analysis;Lancet,2022

2. World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. https://www.who.int/initiatives/glass. Accessed: December 2023.

3. Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options;Sheu;Front Microbiol,2019

4. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents;Kadri;Clin Infect Dis,2018

5. Epidemiology of carbapenem resistance determinants identified in meropenem-nonsusceptible Enterobacterales collected as part of a global surveillance program, 2012 to 2017;Kazmierczak;Antimicrob Agents Chemother,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3